Flow cytometric analysis of Foxp3 / Transcription Factor Staining Buffer Set fixed and permeabilized Human PBMC (human peripheral blood mononuclear cells) labelling Human FOXP3 antibody at 1/2000 dilution (0.1 μg) / (Right panel) compared with a Mouse IgG1 (Left panel) isotype control. Goat Anti - Mouse IgG Alexa Fluor® 647 was used as the secondary antibody. Then cells were stained with CD4 - Phycoerythrin antibody separately.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | FOXP3 |
Synonyms | Forkhead box protein P3; Scurfin; IPEX |
Location | Cytoplasm, Nucleus |
Accession | Q9BZS1 |
Clone Number | S-2903 |
Antibody Type | Mouse mAb |
Isotype | IgG1 |
Application | ICFCM |
Reactivity | Hu |
Positive Sample | Human PBMC |
Purification | Protein G |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
ICFCM | 1:2000 | Hu |
Background
FOXP3 protein is a crucial transcription factor that plays a central role in the development and function of regulatory T cells (Tregs), which are essential for maintaining immune tolerance and preventing autoimmune diseases. It is predominantly expressed in Tregs and helps suppress the activity of other immune cells, thereby preventing excessive immune responses. Mutations or dysfunction in the FOXP3 gene can lead to severe autoimmune disorders such as IPEX syndrome, highlighting its importance in immune regulation. Additionally, FOXP3 has been implicated in various other biological processes, including cancer immunology, where its expression in tumor-infiltrating Tregs can influence the tumor microenvironment and affect the efficacy of immunotherapies.
Picture
Picture
FC
